Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01176890
What this trial is testing

Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects

Who this might be right for
Vagotomy, Truncal
University Hospital, Gentofte, Copenhagen 30
Early research (Phase 1)UnknownNCT06520540
What this trial is testing

HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Who this might be right for
Glucagon-Like Peptide-1 Receptor Agonists
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 72
Post-approval studies (Phase 4)Enrolling By InvitationNCT07057310
What this trial is testing

Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women

Who this might be right for
ObesityMenopause
Mayo Clinic 30
Early research (Phase 1)Looking for participantsNCT06891287
What this trial is testing

An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.

Who this might be right for
Obesity
RANI Therapeutics 60
Not applicableNot Yet RecruitingNCT07588984
What this trial is testing

GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study

Who this might be right for
Obesity & OverweightWeight LossPreventative Health+2 more
Noom Inc. 2,310
Post-approval studies (Phase 4)Study completedNCT02589626
What this trial is testing

Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 65
Not applicableUnknownNCT01977833
What this trial is testing

Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Tel Aviv University 30
Large-scale testing (Phase 3)Study completedNCT00763815
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

Who this might be right for
Diabetes Mellitus Type 2
Sanofi 484
Testing effectiveness (Phase 2)Study completedNCT06400615
What this trial is testing

Study That Tests AD109 in Patients Taking GLP-1 Drugs

Who this might be right for
OSA
Apnimed 40
Not applicableStudy completedNCT00612625
What this trial is testing

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

Who this might be right for
Diabetes Mellitus Type 2
Hvidovre University Hospital 9
Not applicableStudy completedNCT02796950
What this trial is testing

The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion

Who this might be right for
Diabetes Mellitus Type 2
University of Aarhus 8
Not applicableUnknownNCT06388213
What this trial is testing

Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

Who this might be right for
Diabetes Mellitus, Type 2AnesthesiaPulmonary Aspiration of Gastric Contents
University Hospital, Geneva 40
Large-scale testing (Phase 3)Study completedNCT01847313
What this trial is testing

The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Karl Neff 20
Post-approval studies (Phase 4)Ended earlyNCT00799435
What this trial is testing

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

Who this might be right for
Diabetes Mellitus, Type 2Heart Failure, Diastolic
Baylor College of Medicine 2
Post-approval studies (Phase 4)Study completedNCT01761318
What this trial is testing

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

Who this might be right for
Diabetes Mellitus Type 2Metabolic SyndromeCardiovascular Disease+2 more
Leiden University Medical Center 50
Early research (Phase 1)Study completedNCT00530309
What this trial is testing

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 40
Testing effectiveness (Phase 2)UnknownNCT02829502
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke

Who this might be right for
Ischemic Stroke
Christina Kruuse 30
Not applicableStudy completedNCT00673894
What this trial is testing

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

Who this might be right for
Type 2 Diabetes
Garvan Institute of Medical Research 22
Testing effectiveness (Phase 2)UnknownNCT04305002
What this trial is testing

Exenatide Treatment in Parkinson's Disease

Who this might be right for
Parkinson Disease
Center for Neurology, Stockholm 60
Not applicableLooking for participantsNCT07195994
What this trial is testing

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Who this might be right for
Prediabetes / Type 2 Diabetes
QuickSilver Scientific 90
Next Page